Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe asthma: One disease and multiple definitions.
Bagnasco D, Paggiaro P, Latorre M, Folli C, Testino E, Bassi A, Milanese M, Heffler E, Manfredi A, Riccio AM, De Ferrari L, Blasi F, Canevari RF, Canonica GW, Passalacqua G; SANI (Severe Asthma Network Italy); Severe Asthma Network Italy. Bagnasco D, et al. Among authors: testino e. World Allergy Organ J. 2021 Nov 19;14(11):100606. doi: 10.1016/j.waojou.2021.100606. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34871335 Free PMC article.
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.
Bagnasco D, Massolo A, Bonavia M, Brussino L, Bucca C, Caminati M, Canonica GW, Caruso C, D'Amato M, De Ferrari L, Guida G, Heffler E, Lombardi C, Menzella F, Milanese M, Paoletti G, Riccio AM, Rolla G, Senna G, Testino E, Passalacqua G. Bagnasco D, et al. Among authors: testino e. Allergy. 2020 Jun;75(6):1460-1463. doi: 10.1111/all.14135. Epub 2020 Feb 23. Allergy. 2020. PMID: 31773742 Free article. No abstract available.
One year of mepolizumab. Efficacy and safety in real-life in Italy.
Bagnasco D, Caminati M, Menzella F, Milanese M, Rolla G, Lombardi C, Bucca C, Heffler E, Paoletti G, Testino E, Manfredi A, Caruso C, Guida G, Senna G, Bonavia M, Riccio AM, Canonica GW, Passalacqua G. Bagnasco D, et al. Among authors: testino e. Pulm Pharmacol Ther. 2019 Oct;58:101836. doi: 10.1016/j.pupt.2019.101836. Epub 2019 Aug 29. Pulm Pharmacol Ther. 2019. PMID: 31473366
Specific Therapy for T2 Asthma.
Bagnasco D, Testino E, Nicola S, Melissari L, Russo M, Canevari RF, Brussino L, Passalacqua G. Bagnasco D, et al. Among authors: testino e. J Pers Med. 2022 Apr 7;12(4):593. doi: 10.3390/jpm12040593. J Pers Med. 2022. PMID: 35455709 Free PMC article. Review.
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients.
Latorre M, Rizzi A, Paggiaro P, Baiardini I, Bagnasco D, DelGiacco S, Lombardi C, Patella V, Nucera E, Parente R, Paoletti G, Pini L, Ridolo E, Senna G, Blasi F, Canonica GW, Aruanno A, Ballacchino C, Bonavia M, Calabrese C, Caminati M, Carbonara M, Cardini C, Caruso C, Cattani L, Crivellaro MA, Diana A, Durante E, Favero E, Barbaro MPF, Frateiacci S, Guarnieri G, Lofaro A, Losa F, Magarò N, Menzella F, Ricciardi L, Scioscia G, Testino E, Torracca F. Latorre M, et al. Among authors: testino e. J Asthma. 2024 Apr 5:1-26. doi: 10.1080/02770903.2024.2338863. Online ahead of print. J Asthma. 2024. PMID: 38578082
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Bagnasco D, Nicola S, Testino E, Brussino L, Pini L, Caminati M, Piccardo F, Canevari RF, Melissari L, Ioppi A, Guastini L, Lombardi C, Milanese M, Losa F, Robbiano M, De Ferrari L, Riccio AM, Guida G, Bonavia M, Fini D, Balbi F, Caruso C, Paggiaro P, Blasi F, Heffler E, Paoletti G, Canonica GW, Senna G, Passalacqua G, On Behalf Of Sani. Bagnasco D, et al. Among authors: testino e. Biomedicines. 2023 Aug 30;11(9):2424. doi: 10.3390/biomedicines11092424. Biomedicines. 2023. PMID: 37760865 Free PMC article.